Skip to main content

Table 1 Baseline demographic and clinical characteristics of the patients

From: Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia

  ITT PP
  Triple therapy Sequential therapy Triple therapy Sequential therapy
Number of patients 44 364 40 345
Age (Mean ± SD) 52.6 ± 9.5 51.0 ± 11.2 53.7 ± 9.0 51.1 ± 11.2
Gender (%)     
 Male 9 (20.5 %) 135 (37.1 %) 7 (17.5 %) 127 (36.8 %)
 Female 35 (79.5 %) 229 (62.9 %) 33 (82.5 %) 218 (63.2 %)
Endoscopic finding     
iDU 44 (100 %) 126 (34.6 %)   
NUD   238 (65.4 %)   
Eradication success 34 304 34 304
Eradication rate 77.3 % 83.5 % 85.0 % 88.1 %
 95 % CI 64.9–89.7 % 79.9–87.3 % 73.9–96.1 % 84.7–91.5 %
 P-value 0.29 0.57
  1. ITT intention to treat, PP per protocol